Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Status:
Completed
Trial end date:
2020-12-22
Target enrollment:
Participant gender:
Summary
This study will be an open-label, parallel-arm study to determine if a prior intra-articular
(IA) injection of lorecivivint (LOR) affects the safety, tolerability, and/or
pharmacokinetics (PK) of a subsequent IA injection of the corticosteroid triamcinolone
acetonide (TA) into the same knee, and to determine if a prior IA injection of TA affects the
safety or tolerability of a subsequent IA injection of LOR into the same knee.